- Home
- LGHL vs INM Comparison
LGHL vs INM Comparison
Compare LGHL & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGHL
- INM
- Stock Information
- Founded
- LGHL 2015
- INM 1981
- Country
- LGHL Singapore
- INM Canada
- Employees
- LGHL N/A
- INM N/A
- Industry
- LGHL Investment Bankers/Brokers/Service
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- LGHL Finance
- INM Health Care
- Exchange
- LGHL Nasdaq
- INM Nasdaq
- Market Cap
- LGHL 4.4M
- INM 4.1M
- IPO Year
- LGHL N/A
- INM N/A
- Fundamental
- Price
- LGHL $0.82
- INM $1.72
- Analyst Decision
- LGHL
- INM
- Analyst Count
- LGHL 0
- INM 0
- Target Price
- LGHL N/A
- INM N/A
- AVG Volume (30 Days)
- LGHL 144.9K
- INM 74.5K
- Earning Date
- LGHL 01-01-0001
- INM 11-13-2025
- Dividend Yield
- LGHL N/A
- INM N/A
- EPS Growth
- LGHL N/A
- INM N/A
- EPS
- LGHL N/A
- INM N/A
- Revenue
- LGHL N/A
- INM $4,942,633.00
- Revenue This Year
- LGHL N/A
- INM N/A
- Revenue Next Year
- LGHL N/A
- INM N/A
- P/E Ratio
- LGHL N/A
- INM N/A
- Revenue Growth
- LGHL N/A
- INM 7.50
- 52 Week Low
- LGHL $0.71
- INM $1.67
- 52 Week High
- LGHL $16.40
- INM $8.27
- Technical
- Relative Strength Index (RSI)
- LGHL 33.14
- INM 27.48
- Support Level
- LGHL $0.71
- INM $1.67
- Resistance Level
- LGHL $1.18
- INM $1.92
- Average True Range (ATR)
- LGHL 0.10
- INM 0.09
- MACD
- LGHL -0.02
- INM -0.03
- Stochastic Oscillator
- LGHL 20.91
- INM 8.73
About LGHL Lion Group Holding Ltd.
Lion Group Holding Ltd is an investor-focused trading platform that offers various products and services. The company's current business lines include total return swap (TRS) trading business, contracts for difference (CFD) trading services, Hong Kong-based Over-The-Counter (OTC) stock options trading business, and futures and securities brokerage services. It provides these services through its Lion Brokers Pro and a variety of other applications. The company generates a majority of its revenue from its CFD trading services business. Geographically, the firm's key revenue-generating market is Hong Kong.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.